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ABSTRACT 
 
Arsenic is a commonly toxin found in the natural environment and from anthropogenic sources. 
Arsenic exposure can produce multiple adverse effects including chronic lung disease and lung 
cancer. The Ubiquitin Proteasome System (UPS) is involved in disease development and aging, 
its dysfunction can cause improper degradation of misfolded and unfolded proteins. UPS is 
regulated, in part, by zinc finger gene, thus zinc finger gene can mediate protein degradation, 
disease development and aging. Zinc finger AN1-type domain 2A (ZFAND2A) can be induced 
by arsenic and heat shock, and it plays an important role in maintaining cellular homeostasis and 
longevity. Here, we present a short review about arsenic-induced diseases, the UPS protein 
degradation machinery, and ZFAND2A and a preliminary study addressing ZFAND2A expression 
in NCI-H441 cell (human lung adenocarcinoma epithelial cell line) following treatment with heat 
shock or sodium arsenate. H441 cells appear to be resistant to the arsenic cytotoxicity and 
ZFAND2A increased markedly in these cells in response to heat stress or arsenic exposure. 
Because ZFAND2A is thought to improve UPS function and thus could be viewed as protective 
to cancer cells, it has significant public health relevance, future studies targeting ZFAND2A may 
be useful in the development of novel therapies to lung cancer. 
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1.0 INTRODUCTION 
 
1.1 ARSENIC AND LUNG DISEASE 
 
 
 
 
Arsenic is an environmental toxicant present in food (e.g., seafood or rice), water, air, and soil 
(Earth’s crust component).  Arsenic exposures result from anthropogenic processes including use 
in pesticides, herbicides, wood preservatives, and dye-stuffs.   Ingestion and dermal contact are 
the main routes of exposure.   Drinking water contaminated by arsenic has been a major caused 
of extensive chronic poisoning, thus remains a major public health concern worldwide. 
 
 
 
1.2 ARSENIC EXPOSURE 
 
 
Arsenic is a metalloid, which means that it can display properties of both a metal and a nonmetal. 
There are several structural forms and oxidation states of arsenic because it can form alloys with 
metals and covalent bonds with hydrogen, oxygen, carbon, and other elements. Environmentally 
relevant forms of arsenic are inorganic and organic existing in the trivalent (III) or pentavalent 
(V) state. Inorganic arsenic persists in human body for longer time than organic forms due to 
different metabolic mechanisms. The more potent arsenic compounds are trivalent inorganic 
forms, such as arsenic trioxide (As2O3) and sodium arsenite (NaAsO2). 
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1.2.1 Current Exposure Limits 
 
 
The No Observed Adverse Effect Level (NOAEL) for inorganic arsenic is 0.009 mg/L (0.0008 
mg/kg ⋅ day), the Lowest Observed Adverse Effect Level (LOAEL) is 0.17 mg/L (0.014 mg/kg 
  day) (Environmental Protection Agency 1998), and the reference dose (RfD) is 3E-4 mg/kg 
 
  day. The maximum contamination level (MCL) suggested by the World Health Organization 
(WHO) and the U.S. Environmental Protection Agency (EPA) is 10 μg/L currently 
(Environmental Protection Agency 2001), which was 50 μg/L prior to 2001 (National Research 
Council 2001). This level could be reduced in the future as technology and research allows, 
because 10 μg/L of arsenic may not have an adequate margin of safety. Cancer-death risk 
associated with consumption of 1.6 liters of water per day with inorganic arsenic 50μg/L⋅ day has 
been estimated to be 21/1,000 (Bates et al., 1992). 
 
 
1.2.2 Extend of Human Exposure 
 
 
Worldwide, 160 million people are estimated to have been exposed to arsenic contaminated 
drinking water at concentration above the recommended exposure limits recommended by the 
WHO and EPA (IARC Working Group 2004).  These exposures occur in geological areas where 
the Earth’s crust composition is rich in arsenic. Especially in developing countries, such as 
Bangladesh, Chile, Argentina, Mexico and Taiwan, high levels of arsenic are naturally present in 
drinking water and cause significant public health concerns.  In some regions, well water arsenic 
concentrations can exceed 1 mg/L and in these areas the crude lung cancer specific mortality is 
higher than the average level of the world. 
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1.3 ARSENIC NON-LUNG DISEASES 
 
 
Arsenic can cause cell damage and cell death via arsenic-induced oxidative stress, and chronic 
exposure of arsenic-contaminated drinking water has been shown to link with various kinds of 
diseases in different body systems. 
 
 
1.3.1 Dermal disease 
 
 
The skin, a major target organ in chronic arsenic exposure, can develop skin lesions including 
hyperkeratosis and both hyperpigmentation, and hypopigmentation (Mazumder et al., 1998). 
Dermal effects are hallmarks of early stages of arsenic poisoning. In southwest Taiwan, 
Blackfoot disease is commonly caused by chronic exposure of high arsenic-contained drinking 
water. An epidemiological study conducted in the Gangetic plain of West Bengal, India and 
neighboring Bangladesh where the population was exposed to water with arsenic concentrations 
in excess of 50 μg/L, found that males tend to have a higher prevalence rate of arsenic skin 
lesions than females (Chowdhury et al., 2000). Skin cancer can be caused by chronic exposure 
to arsenic in drinking water and it is one of the most common form of neoplasm associated with 
arsenic ingestion (Mead 2005). 
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1.3.2 Cardiovascular disease 
 
 
Epidemiological studies has have noted that cardiovascular system is particularly sensitive to 
arsenic exposure. In Taiwan, elevated mortality has been reported for ischemic heart disease 
(ISHD) (Chen et al., 1988), indicating that an increased risk of coronary heart disease is 
associated with long-time exposure to inorganic arsenic (Tchounwou et al., 2003). Hypertension, 
peripheral atherosclerosis, cardiac arrhythmias and other cardiovascular conditions can also be 
induced by chronic ingestion of arsenic-contaminated drinking water. 
 
 
1.3.3 Neurological Disorders 
 
 
Exposure of inorganic arsenic can cause nervous system injury, characterized by both central and 
peripheral neuropathy (Vahidnia et al., 2007). A reduced nerve conducting velocity in peripheral 
nerves is a hallmark of arsenic-induced neurotoxicity (Mathew et al., 2010). For children, the 
adverse effect is even worse and impaired cognitive effect have been reported in adolescents 
following by chronic arsenic exposure of drinking water (Tsai et al., 2003). 
 
 
1.3.4 Other diseases 
 
 
In addition, to dermal, cardiovascular, and neurological effects, arsenic can produce 
adverse hepatic, renal, reproductive, and immunological effects. Chronic arsenic exposure can 
cause liver injury, which is presented as jaundice, abdominal pain, and hepatomegaly (NRC, 
2001: Mazumder, 2005), and progress to cirrhosis and ascites, and even liver cancer (Liu and 
Waalkes, 2008; Straif et al., 2009; IARC, 2011).  Inorganic arsenic compounds do not cause any 
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significant renal injury in humans, while organic forms can cause renal and bladder effects 
following oral exposure in animal models, including bladder cancer (Jomova et al., 2011). 
Arsenic exposure has reproductive health effects, including reduced weights of the uterus and 
ovary and reduced ovarian and uterine peroxidase activities in mice model (Chattopadhyay et al., 
2001). Arsenic exposure also has immunotoxic effects (ATSDR, 2005),  thus  people  with 
chronic arsenic exposure are more susceptible to inappropriate inflammatory and wound healing 
responses. 
 
 
 
1.4 ARSENIC LUNG DISEASE 
 
 
1.4.1 Cancer 
 
 
Arsenic has been classified as a class I human carcinogen by the International Agency of 
Research on Cancer (IARC), meaning that there is sufficient evidence of carcinogenicity to 
humans. 
 
1.4.1.1 Molecular mechanism of lung cancer 
 
i) The development of cancer is associated with arsenic-induced oxidative stress via 
reactive oxygen species (ROS) and reactive nitrogen species (RNS). 
Arsenic-induced oxidative stress can cause cell damage and death through activation of oxidative 
sensitive signaling pathways (Roy et al., 2009). Many studies confirmed the generation of 
various types of ROS during arsenic metabolism in cells (Valko et al., 2005).  Major arsenic- 
induced  ROS  include  superoxide  anion  (O2 • −  ), hydroxyl  radical (   • OH),  hydrogen  peroxide 
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(H2O2), singlet oxygen (1O2), and peroxyl radicals (Flora et al., 2011). Superoxide anions are 
considered “primary” ROS. They can further interact directly, through enzyme or metal- 
catalyzed processes, with other molecules to generate “secondary”ROS (Valko et al., 2005). 
ROS have been demonstrated to be involved in the signaling of the cell transformation response 
(Li et al., 1998) and can affect cytoplasmic and nuclear signal transduction  pathways  that 
regulate gene expression (Sen et al., 1997), thus cause cell damage and death. These effects are 
important in tumor promotion. In addition to ROS, RNS are also thought to be directly involved 
in oxidative damage to lipids, proteins and DNA in cells exposed to arsenic (Shi et al., 2004). 
ii) Arsenic alters gene expression patterns, causes DNA damaging, and inhibits DNA repair 
by altering histone modification. 
Although arsenic may not be a classic mutagen which can cause point mutations (Huang 2004), 
it can induce large deletion mutations (Hei 1998).  Also, arsenite inhibits the completion of DNA 
excision repair, perhaps via effects on DNA ligase, which is especially sensitive to arsenite in the 
cell (Li 1989).  Histone post-translational modification is a key step that may result in an 
epigenetic mark that regulates chromatin structure and gene transcriptional activity thereby 
impacting many fundamental aspects of human biology (Zou 2014).  Arsenic can modify H3K4, 
H3K9, and H3K27 histone methylation patterns in both malignant and nonmalignant lung cell 
lines, leading to decreased expression of genes associated with histone acetylation and DNA 
methylation changes (Jensen 2008; Zhou 2008). 
 
 
1.4.1.2 The association between arsenic and lung cancer 
 
High-level, chronic arsenic exposure (i.e. >100 µg/L in water), lung cancer mortality rate is dose 
dependent (Hopenhayn-Rich et al., 1998).  In Northern Chile, increasing arsenic concentration 
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exposure in drinking water was associated with increased lung cancer incidence (Nicolli et al., 
1985). Furthermore, cigarette smoking can increase the risk of lung cancer when combined with 
ingestion of arsenic (Begum et al., 2012). There is a substantial heterogeneity in lung cancer risk 
among people with similar exposure levels worldwide, which may due to genetic variation, diet 
habit, and the exposure patterns (arsenic species) (Celik et al., 2008). 
Medium- or low-level chronic arsenic exposure do not demonstrate a similar 
concentration depend association with lung cancer mortality, which has been shown in studies 
conducted in Denmark where arsenic concentration in drinking water ranged from 0.05 to 25 
µg/L and in Belgium where arsenic concretion ranged from 20-50 µg/L (Baastrup et al., 2008; 
Buchet et al., 1998). 
 
 
1.4.2 Chronic obstructive pulmonary disease (COPD) 
 
 
Arsenic-induced stress can cause a misfolded and unfolded protein response, which are 
significant for disease development, including COPD. An epidemiological study in Chile (Smith 
et al., 1998) found that young people living in areas of high arsenic exposure have high relative 
rates for COPD mortality. Among people aged from 30 to 39, 4 deaths from COPD occurred in 
males (0.8 expected), and 6 in females (0.1 expected) with men and women combined standard 
mortality ratio (SMR) = 11.1, 95% confidence interval (CI): 5.3-20.4 (p<0.001). The author 
suggested that early exposure to arsenic was important and led to the elevated COPD mortality 
rates in younger adults, since the mortality rate was not increased in older age groups (Mazumder 
et al., 2000). 
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1.4.3 Bronchiectasis, bronchitis 
 
 
The prevalence of bronchiectasis was found to be 23-fold greater among children who 
have arsenic-induced skin symptoms onset (skin lesion) living in Antofagasta than children live 
in the rest of Chile (Zaldivar et al., 1980). An association between chronic arsenic ingestion and 
chronic bronchitis was reported in a small cross-sectional study among 94 individuals (Milton et 
al., 2001). In Bangladesh, another study was conducted in a population of 218, and results 
showed that the crude prevalence ratio for chronic bronchitis was 10.3 (95% CI: 2.4-43.1) for 
females and 1.6 (95% CI: 0.8-3.1) for males (Mazumder Guha 2007). 
 
 
1.4.4 Other respiratory disorders 
 
 
Chronic arsenic exposure induced respiratory effects was first noted in a arsenic-affected village, 
West Bengal, in 1995, when 57% of the 156 patients were reported to have chronic cough 
(Mazumder Guha et al., 1997). Chest sounds also could be caused by chronic arsenic ingestion. 
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2.0 THE UBIQUTIN PROTEASOME SYSTEM (UPS) 
 
 
 
 
Ubiquitin proteasome system (UPS) functions to degrade unneeded or damaged proteins by 
proteolysis, a chemical reaction that breaks peptide bonds. Enzymes that carry out such reactions 
are called proteases. Proteasomes are part of a major mechanism by which cells regulate the 
concentration of particular proteins and degrade damaged or misfolded proteins. UPS is also 
involved in cell cycle controlling and the arsenic-induced alteration process of DNA expression 
and repair, it is also associated with aging. Properly functioning proteasome is essential for 
numerous cellular processes, including protein turn over and quality control, cell growth and 
signaling, immune response and antigen presentation. Dysfunction of UPS can cause the 
accumulation of misfolded and unfolded proteins, thus associated with disease development and 
aging. In addition, accumulation of damage proteins can lead to apoptosis. Apoptosis is 
programmed cell death which is controlled by cell signal transduction. Properly functioning 
apoptotic mechanisms are crucial for the removal of damaged cells and the prevention of cancer 
development (Leonard 2004), an imbalance in cell proliferation and cell death can lead to cancer 
development. 
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2.1 THE UBIQUITIN ENZYME CHAIN 
 
 
2.1.1 E1, E2, E3 Ubiquitin Protein Ligases 
 
 
Ubiquitination is needed for substrate (target protein) to be recognized by the proteasome before 
degradation, it is a complicated process in an ATP-dependent fashion and involves many 
enzymes. First, the terminal carboxyl group of ubiquitin is joined in a thioester bond to a 
cysteine residue on ubiquitin activating enzyme (E1), then transferred to a sulfhydryl group on a 
ubiquitin-conjugating enzyme (E2), and last to a specific target protein, a critical event that is 
catalyzed by a ubiquitin E3 ligase (Weathington et al., 2013a). The last step promotes transfer 
of ubiquitin from E2 to the ε-amino group of a lysine residue of a protein recognized by that E3, 
and forms an isopeptide bond. Skp1–Cullin–F-box protein (SCF), a multi-protein E3 ubiquitin 
ligase complex, catalyzing the ubiquitination of proteins destined for proteasomal degradation 
(Weathington et al., 2013 b) and can be inhibited by arsenic through PI3K/Akt pathway (Zhang 
et al., 2008). 
 
 
2.1.2 E3 ligases are most important 
 
 
E3 is crucial in orchestrating the ubiquitination of target proteins. After the target gene has 
undergone some post-translational modification and generates a “degron” (a specific structural 
motif) (Glickman and Ciechanover, 2002), E3 shuttles the target gene for degradation. The 
whole processes of targeting, ubiquitination, and degradation of proteins are specific and highly 
regulated (Weathington et al., 2013b). 
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There are two major E3 ligase families, the RING (really interesting new gene) and the 
HECT (homologous to the E6-AP carboxy terminus) proteins. The RING finger and RING- 
related proteins are the largest E3 ligase family, whose members can ubiquitinate a broad range 
of substrates, either independently as monomers or dimers, or in a multisubunit complex. The 
HECT domain-containing proteins are a smaller E3 family, whose members are significant in 
regulating proteins, including the transmembrane surface proteins (Weathington et al., 2013a). 
 
 
 
2.2 PROTEASOME STRUCTURE AND FUNCTION 
 
 
After the substrate is “marked” through polyubiquitination, it is degraded by the 26S proteasome 
protein complex, which is composed of one 20S (a catalytic core) and two 19S proteolytic 
subunits (Glickman et al., 2002). 
 
 
2.2.1 Structure 
 
 
2.2.1.1 20S proteasome (28-subunint) 
 
Two outer rings are composed of 7 alpha subunits [(prosome, macropain) subunit, alpha type 
(PSMA 1-7)] and 2 inner rings are composed of 7 beta subunits (PSMB1-7). 
The 20s has a barrel-like structure, with two-fold symmetry (Meiners and Eickelberg, 
2012). The proteasome’s proteolytic active sites are sequestered within the largest internal space 
of it. Once substrates access into the proteolytic chamber of the free core, it is blocked through 
an essentially topological mechanism (Finley 2009). 
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2.2.1.2 19S proteasome 
 
 
The 19S regulator is composed of a base, which contains 6 ATPase subunits and 2 non-ATPase 
subunits, and a lid, which contains up to 10 non-ATPase subunits. This component 
deubiquitylates, unfolds, and translocates the recruited protein to the 20S catalytic chamber. 
It unfolds target protein before the protein is translocated into the core particle. The 
“lid”, serves regulatory functions, including polyubiquitinated proteins binding and substrates 
de-ubiquitination. And the “base” mediates energy-dependent unfolding of substrates and makes 
the access to the 20s core particle chamber open (Meiners and Eickelberg, 2012). 
 
 
2.2.2 Protein degradation function 
 
 
2.2.2.1 Protein to amino acids 
 
Although many studies have focused on the initial steps in the protein degradation 
process, such as the ubiquitination of polypeptides and their degradation in proteasomes, very 
few have been focusing on the degradation of the proteasome’s products to amino acids, and the 
enzymes involved in this process remain to be unknown (Goldberg et al., 2002). For large 
proteasome products in cytosolic degradation, it proceeds through two steps. First, large peptides 
are cleaved by thymet oligopeptidase (TOP) and probably other unidentified endopeptidase(s). 
Then, the products generated from the first step can be further degraded by bestatin-sensitive di- 
or tri-peptidases to single amino acids. For shorter proteasome products, they are degraded 
directly by various aminopeptidases to amino acids (Goldberg et al., 2002). 
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2.2.2.2 Protein to peptides 
 
The proteasome produces highly heterogeneous peptides mixture from a particular target protein. 
These peptides serve as raw material for adaptive cell-mediated immunity in mammals (Kisselev 
et al., 1999). Proteasomes containing proteasome (prosome, macropain) 26S subunit, non- 
ATPase, 8 (PSMD8), PSMD9, and PSND10 subunits are call the immunoproteasomes. This unit 
generates 8-10 amino acid peptides for docking with major histocompatibility (MHC) class I. 
These peptide-MHC complexes form in the endoplasmic reticulum after the exportation of the 
peptides from cytoplasm via the peptide-specific TAP transporter. The peptide-MHC complex 
may be recognized by epitope-specific T cell receptor after it routes to the cell surface. If the 
presented epitope is derived from “foreign” sources, such as viruses and tumors, this process can 
initiate apoptosis (Finley 2009). 
 
 
2.2.3 Regulatory protein degradation by the UPS 
 
 
2.2.3.1 Example 1: Hypoxia Inducible Factor 1, alpha subunit (basic helix- 
loop-helix transcription factor) (HIF1A) and von Hippel-Lindau Tumor 
Suppressor, E3 Ubiquitin Protein Ligase (VHL). 
The UPS is mediates cellular functions via HIF1A, which is a potent transcriptional activator of 
many stress response proteins, such as growth factors, chemokines and proteases (Weathington 
et al., 2013 b). HIF1A protein hydroxylation is regulated differently under normoxic and 
hypoxia conditions. HIF1A protein is important in both normal growth and neoplasia, where 
cancer cells with limited blood supplies. An E3 ligase, VHL mediates HIF-1α polyprotein 
ubiquitination and disposal by the proteasome (Jaakkola et al., 2001). This process regulates 
HIF-1α protein concentrations to modulate cell growth and survival responses, it also controls 
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edema formation during lung injury. The HIF1A-VHL signaling axis is associated with 
oncogenesis (Weathington et al., 2013b). 
 
 
2.2.3.2 Example 2: Nuclear Factor of kappa Light Polypeptide Gene 
Enhancer in B-Cells Inhibitor, alpha (NFKBIA) and Beta-Transducin Repeat 
containing E3 Ubiquitin Protein Ligase (BTRC) protein-protein interaction. 
The Skp1–Cullin–F-box protein (SCF) family is the largest family of Culling-RING E3 ligases 
that mediates ubiquitination of post-translationally modified target proteins or substrates often 
for proteasomal degradation (Weathington et al., 2013b). In this family, FBP (F-box proteins) is 
crucial for affecting changes in cellular states, including cell cycle progression, it is also related 
to critical pathways of pulmonary homeostasis and disease. One F-box protein is beta-transducin 
repeat containing E3 ubiquitin protein ligase (BTRC aka FBXW1). 
Innate immune responses are triggered by the detection of pathogen-associated molecular 
patterns (PAMPs) that bind to cell membrane receptors including toll-like receptors (TLRs). 
TLRs recruit a set of adaptor proteins with TIR domains by homophilic interaction of their TIR 
domains. These interactions result in triggering of downstream signaling cascades leading to the 
activation of transcription factor nuclear factor-kappa B (NFKB), which controls induction of 
proinflammatory cytokines and chemokines as well as the modulation of co-stimulatory 
molecules on dendritic cells that are essential for T-cell activation. NFKB is typically held 
inactive by a family of IκB inhibitor proteins including NFKBIA. The WD40 repeats in BTRC 
can bind phosphorylated NFKBIA, which induces polyubiquitylation and, subsequently, 
degradation of NFKBIA. This is an essential step for the release of NFKB from the NFKB- 
NFKBIA complex, and it leads to the nuclear translocation and transcriptional activation of 
NFKB targets.   In addition, BTRC can mediate degradation of CD4 via its interaction with HIV- 
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1 Vpu. Other F-box protein species also have been identified to be related with pulmonary 
inflammation at level of cytokine receptor stability, surfactant homeostasis, and inflammatory 
signaling (Weathington et al., 2013b). 
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3.0 PROTEOSOME ASSOCIATED PROTEINS 
 
 
 
 
As mentioned before, the proteasome has a cylindrical structure with a “lid” and a “base”, and 
the active sites in α and β subunits face the interior of the cylinder. The ubiquitin-independent 
substrates must pass through an open core particle channel to be degraded after being unfolded. 
The CP gate is in closed status by default, and the modulation of the gate is regulated by several 
proteasome activators (Schmidt and Finley 2014). 
 
 
 
 
 
3.1 CLASSIC ACTIVATORS (11S/REG/PA28) 
 
 
The PA28/11S/REG proteasome activator family is expressed in eukaryotes. There are three 
isoforms in PA28: PA28α, PA28β and PA28γ, they utilize the activation loop (internal loop 
structure) to promote opening the CP gate by contacting the 20s alpha subunits (Schmidt and 
Finley 2014). PA28α and PA28β form hetero-heptameric rings in vertebrates, and induced by 
interferon-γ, which indicates that PA28α and PA28β in MHC Class I may mediate antigen 
presentation (Realini et al., 1997). However, the cellular function of them has not fully 
understood yet. PA28γ forms homo-heptameric rings and is found in the nuclei of both 
vertebrates and invertebrates (Dubiel 1992; Ma 1992). It promotes the degradation of specific 
small regulatory proteins in an ATP-and ubiquitin-independent way. 
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3.2 ZINC FINGER, AN1-TYPE DOMAIN PROTEIN FAMILY 
 
 
3.2.1 Zinc Finger, An1 Domain Protein Structure 
 
 
The zinc finger, AN1-type domain (ZFAND) protein family consists of 6 proteins: ZFAND1, 
2A. 2B, 3, 4, 5, and 6. A related protein is immunoglobulin mu binding protein 2. To date the 
most studied are ZFAND2A, ZFAND2B, and ZFAND5. ZFAND proteins contain a N-terminal 
ubiquitin (Ub)-like domain C-terminus a zinc finger, AN1 domain, which was original found in 
Xenopus laevis (Linnen et al. 1993). The AN1-type zinc finger consists of 6 conserved 
cysteines and 2 histidines that could potentially coordinate 2 zinc atoms: C-X2-C-X(9-12)-C- 
X(1-2)-C-X4-C-X2-H-X5-H-X-C: Where X can be any amino acid, and numbers in brackets 
indicate the number of residues. This domain was originally thought to have a role in 
determining cell fate, but now is contained in proteins associated with stress responses. 
The uneven distribution of maternal mRNAs in unfertilized eggs and the unequal 
inheritance of these molecules by dividing blastomeres may be one mechanism for determining 
cell fate during embryogenesis. Complementary DNA (cDNA) clones corresponding to 
maternal mRNAs localized to specific regions of the Xenopus laevis egg was identified by 
Rebagliati et al. (1985). The maternal mRNA, An1, was originally identified as being localized 
to the animal hemisphere of X. laevis eggs and early embryos. Unlike Ub polyproteins and 
most Ub fusion proteins, Linnen et al. (1993) found that the N-terminal Ub-like domain 
found in the An1 proteins does not undergo proteolytic processing, and that An1 transcripts are 
present in later embryonic stages and in all adult tissues. Moreover, AN1 domain in combination 
with A20 zinc finger domains is found in a number of stress associated proteins (SAP).  For 
example SAP gene family in rice, 
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whose members were all inducible by abiotic stress, indicating that this gene help to build 
tolerance under stress in plants (Vij 2006). 
 
 
3.2.2 Zinc finger, AN1-type domain 5 (ZFAND5 aka Znf216) 
 
 
ZFAND5A is protein that contains an AN1 zinc-finger at the C terminus and an A20 zinc-finger 
at the N terminus and can negatively regulate the NFΚB activation pathway by interacting with 
immune response proteins including receptor (TNFRSF)-interacting serine-threonine kinase 1 
(RIPK1 aka RIP), inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma 
(IKBKG aka IKKγ) and TNF receptor-associated factor 6, E3 ubiquitin protein ligase (TRAF6) 
(Huang 2004). The interaction of ZFAND5 with RIPK1 and IKBKG is mediated by the A20 
zinc-finger domain, while its interaction with TRAF6 is mediated by the AN1-type domain; 
therefore, both zinc-finger domains are involved in regulating the immune response. 
Very little is known about human ZFAND5 protein, however, this protein is similar to 
sequestosome 1 (SQSTM1 aka p62), also is a protein with A20 zinc finger domain, which can 
inhibit NFKB activation triggered by overexpression of RIPK1 and TRAF6 (Komatsu et al. 
2012). A stress-inducible intracellular protein, SQSTM1 regulates various signal transduction 
pathways involved in cell survival and cell death. Analysis of microtubule-associated protein 1 
light chain 3 alpha (MAP1LC3A aka LC3 (an autophagosome localizing protein)-binding 
proteins resulted in the recognition of autophagy and SQSTM1. Although autophagy modulates 
SQSTM1 protein levels, SQSTM1 can suppress autophagy via activation of mechanistic target of 
rapamycin (serine/threonine kinase) (MTOR). SQSTM1also directs ubiquitinated cargos toward 
autophagy as well as compaction of those cargos. Furthermore, this protein functions as a 
signaling hub for various signal transduction pathways, such as NFKB signaling, apoptosis, and 
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nuclear factor, erythroid 2-like 2 (NFE2L2 aka Nrf2) activation. It also inhibits tumor necrosis 
factor (TNF)- , interleukin-1- , and Toll-like receptor 4-induced NFKB activation in a dose- 
dependent manner. The protein functions as a scaffolding/adaptor protein in concert with TNF 
receptor-associated factor 6 to mediate activation of NF-kB in response to upstream signals. 
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4.0 ZFAND2A 
 
 
 
 
Arsenicals activate multiple stress pathways resulting in the induction of specific genes whose 
identity and role in the adaptation to arsenical-induced cellular stress are poorly understood. Sok 
et al. (2001) identified ZFAND2A, which was initially called arsenite-inducible, cysteine- and 
histidine-rich RNA-associated protein, AIRAP, and reported that is conserved among mammals, 
Drosophila, and Caenorhabditis elegans. Subsequently, Kimura and colleagues (2010) 
determined that ZFAND2A mRNA increased within 3 h in the kidney of BALB/c and C57BL/6 
mice injected with sodium arsenite (NaAs; 13.5 mg/kg). 
Suspecting that protein misfolding caused by exposure to arsenite could be associated 
with transcriptional activation of the AIRAP gene, Stanhill et al. (2006) found that ZFAND2 an 
arsenite-inducible subunit of the proteasome's 19S cap that binds near PSMD2 at the 19S base. 
Arsenite activates the electrophile responsive transcription factors NFE2L2 (Alam 1999; Gong 
2002) and their C. elegans homolog skn-1 (An 2003). In mouse fibroblasts, ZFAND2A was 
induced both by arsenite (25 μM, 4 h) and the electrophile, methyl methanesulphonate (50 μg/ml, 
6 h), but it was not induced by the amino-acid analog azetidine (5 mM, 7 h), the endoplasmic 
recticulum (ER) stress-inducing agents tunicamycin (2.5 μg/ml, 6 h), or thapsigargin (400 nM, 6 
h). In C. elegans, interfering RNA (RNAi) to skn-1inhibited the arsenite-induced increased 
ZFAND2A promoter: green fluorescence protein reporter activity. In addition, skn-1 RNAi 
treatment augmented the heat-shock response of arsenite-treated worms and increased the levels 
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of polyubiquitylated proteins. Thus, both direct interference with ZFAND4A expression and 
blocking an upstream activator skn-1, impaired the ability of C. elegans to cope with arsenite- 
mediated protein misfolding. Stanhill et al. (2006) also generated mouse embryo fibroblasts 
from gene targeted ZFAND2A mice, and transient arsenite exposure (50 µM, 2 h) accumulate 
polyubiquitylated proteins, whose levels subsequently decline, coincidental with AIRAP 
induction. Under the same conditions, ZFAND2A deficient embryo fibroblasts accumulate more 
polyubiquitylated proteins than the wild-type cells, a feature that was reversed by constitutive 
expression of AIRAP from a ‘‘rescuing’’ transgene. 
Because protein misfolding may contribute to aging, Yuns et al (2008) tested the role of 
AIP-1, a C. elegans homologue of mammalian ZFAND2A, and determined that loss of ZFAND2A 
decreased the lifespan and hypersensitivity to misfolding-prone proteins in C. elegans.  NFKB is 
a ubiquitous transcription factor involved in several biological processes, especial stress response 
and induction of inflammatory mediators (Karin 2000). NFKB is retained in the cytoplasm in an 
inactive state by specific inhibitors including NFKBIA. Upon degradation of the inhibitor, 
NFKB moves into the nucleus and activates transcription of specific genes. NFKB 
transcriptional complex is composed of NFKB1 or NFKB2 bound to either rel avian 
reticuloendotheliosis viral oncogene homolog (REL), RELA, or RELB. The most abundant 
protein combination in the NFKB complex contains NFKB1 and RELA. Examining transcripts 
that are increased with stress-inducing copper (400 µM) treatment in HepG2 cells, McElwee et 
al. (2009) found that ZFAND2A was induced 10- and 33 fold at 3 or 6 h, respectively. These 
increases were inhibited with the IMD-3054 (which inhibits NFKB activation) or with siRNA 
directed at RELA, suggesting the involvement of NFKB signaling in the transcriptional 
activation of ZFAND2A. 
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Heat shock transcription factor-1 (HSF1) is the central regulator of heat-induced 
transcriptional responses leading to rapid expression of molecular chaperones that protect 
mammalian cells against proteotoxic stress (Anckar 2007). HSF1 targets specific promoter 
elements (HSE) located upstream of heat shock genes encoding a variety of heat shock proteins, 
including HSP70, HSP90, HSP27, and other proteins of the network. ZFAND2A expression also 
was found to be temperature-dependent and controlled by HSF1 (Rossi 2010).  Transcription is 
triggered at temperatures above 40oC.  For example, human keratinocytes (HaCaT cells) and two 
 
human cancer cell lines (HCT116 colon carcinoma and Jurkat T-cell lymphoma) were incubated 
at 43°C for 40 min and allowed to recover at 37 °C for 90 min. Heat treatment resulted in an 
increase in ZFAND2A and HSP70 mRNA levels in all cell lines. Similar results were obtained in 
human primary blood monocytes subjected to heat stress (43 °C, 40 min) and analyzed at 1.5 and 
3 h after recovery at 37 °C, suggesting that AIRAP expression represents a general response of 
human cells to temperature increase. Chromatin immunoprecipitation (ChIP) analysis 
demonstrated that, HSF1 was recruited to the ZFAND2A promoter rapidly after heat treatment, 
with a kinetics that parallels HSP70 promoter HSF1-recruitment. HSF1-silencing abolished 
heat-induced ZFAND2A promoter-driven transcription, which was rescued by exogenous Flag- 
HSF1 expression. The HSF1 binding HSE sequence in the ZFAND2A promoter critical for heat- 
induced transcription was identified. In a follow-up study, Rossi et al. (2014) treated human 
umbilical vein endothelial cells with a proteaosome inhibitor, bortezomib and measured an 
increase in HSF DNA binding activity by electrophoretic mobility shift assay (EMSA) and in 
ZFAND2 protein levels by Western-blot. ZFAND2A protein increased in bortezomib-treated 
perpherial  blood  monocytes  and  lymphocytes.  In  borteezomib  treated  cell  HSF1and  HSF2 
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formed a heteromeric complex that was recruited to the ZFAND2A promoter, with the HSF1 
positively and HSF2 negatively regulating transcription. 
Additional stress studies involved cultures of human renal epithelial cells derived from 
cortical tissue obtained from nephrectomies treated with cadmium (Garrett 2013). These cultures 
exhibit many of the characteristics of proximal tubule cells and were treated with by various 
Cd2+ concentrations (4.5-45 µM) and multiple times (1-13 days). The transcriptome (microarray) 
analysis revealed transcriptional dynamics and gene interaction using a mutual information- 
based network model. The most prominent network module consisted of a set of transcripts that 
included ZFAND2A along with AKAP12, AKR1B10, AKR1C1, DNAJA4, INHBA, KIF20A, 
and SCL7A11. 
Similarly, ZFAND2A was found to be a part of a gene dysregulation network (GDN) with 
a classifier to assign compounds to their appropriate class (Pronk 2013). Gene pairs in the GDN 
are dysregulated in the sense that they are linked by a common expression pattern in one class 
and differ in this pattern in another class. The classifier gives a quantitative measure on this 
difference by its prediction accuracy. Gene pairs were selected microarray data obtained with 
human keratinocytes (HaCaT cells) treated with 8 sensitizers or 6 irritants. Pairs with known and 
novel markers were found such as HMOX1 and ZFAND2A, ATF3 and PPP1R15A, OXSR1 and 
HSPA1B, ZFP36 and MAFF. 
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5.0 LABORATARY RESEACH PROJECT 
 
 
 
 
5.1 OBJECTIVES 
 
 
The Ubiquitin Proteasome System is involved in cell cycle controlling and aging. The 
accumulation of unfolded protein caused by dysfunction of UPS is significant to disease 
development. ZFAND2A is a zinc-finger protein that is inducible by arsenite (Sok 2001), which 
serves as a regulator of the UPS, associates with 19s-regulatory particle (Stanhill 2006). Thus 
this response regulates the protein degradation machinery and could influence cell apoptosis 
process to counteract proteotoxicity induced by an adverse environment. Thus it has a protective 
function and help to keep cells maintenance and long longevity (Yun 2008). 
Currently, the role that ZFAND2A gene plays in the lung or in cancer cells is uncertain. 
In this project, we explore how ZFAND2A transcripts are altered by heat shock and arsenic- 
induced cell stress. Human epithelial cancer cells were used to observe the performance of this 
gene, and the molecular mechanism and stress-induced change in protein level will be conducted 
in further study to understand the role of this gene in human lung health better. Given that the 
ZFAND2A plays an important role in cell homeostasis, if we could inhibit transcriptional 
activation of this gene or inhibit the function of the encoded protein in injured or cancer cells, 
cell death will be induced in those cells only, we could find a way to promote lung health with 
high specificity. 
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5.2 METHODS 
 
 
This is a laboratory based research project on ZFAND2A expression level in NCI-H441 cell 
(human lung adenocarcinoma epithelial cell line) under cell stress induced by heat shock and 
sodium arsenite. 
 
 
a. Reagents 
 
 
Complete growth medium: The base medium for this cell line is Dulbecco's Modified Eagle's 
Medium (DMEM) (ATCC® 30-2002™) (Manassas, VA). Complete growth medium included 
the following components to the base medium: fetal bovine serum to a final concentration of 
10% and 1% penicillin-streptomycin. 
Serum-free medium: Dulbecco's Modified Eagle's Medium (DMEM) without Phenol Red 
(ATCC® 30-2601™) RPMI-1640, purchased from ATCC. Add 1% penicillin-streptomycin and 
2% glutamin (100×). 
PBS: Phosphate Buffered Saline (D-PBS), 1X (ATCC® 87571™), purchased from ATCC. 
DPBS: Dulbecco's Phosphate Buffered Saline (D-PBS), 1X (ATCC® 30-2200™), purchased 
from ATCC. 
0.05M Sodium arsenic solution: Product number: 35000. Brand: Fluka. Purchased from Sigma- 
Aldrich (Saint Louis MO,). 
RNA isolation solution: SIGMA TRI Reagent®, Product number: 93289. Purchased from 
Sigma-Aldrich.. 
Gene probe: ribosomal protein L32 (RPL32), Catalog No. 4453320. Zinc finger, AN1-type 
domain  2A  (ZFAND2A),  Catalog  No.  4351372.    Activating  transcription  factor  4  (ATF4), 
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Catalog No. 4331182.  Vascular endothelial growth factor A (VEGFA), Catalog No. 4453320, 
all of them were purchased Life Technology (San Diego, CA). 
DNase I treatment kit: Bio-Rad (Hercules, CA)... 
 
iScriptTM cDNA synthesis reaction kit:  Bio-Rad (170-8890). 
 
qRT-PCR master mix: TaqMan® PCR Master Mix, (Life Technologies Cat. No. 4364344). 
 
 
b. Cell culture 
 
 
NCI-H441 cells (human lung adenocarcinoma epithelial cell line) were cultured in complete 
medium at 5% CO2 and 37°C. 
 
c. Treatment Protocol 
 
 
Heat shock: 
 
Dose-response 
 
H441 cells were seeded in 4×12-well plates (0.4×106 cells/well).  After 24h incubation, 
the medium was removed, washed twice with DPBS and then serum-free RPMI was 
added. After 20h serum-starvation, plates were treated at 37℃, 39℃, 41℃, and 43℃ for 
30 min, and recover at 37℃ for 1.5 h.  Then 0.2ml/well Trireagent was added to extract 
RNA for qRT-PCR analysis. 
 
Temporal analysis 
 
H441 cells were seeded in 4×12 well plates (0.4×106 cells/well).  After 24h incubation, 
the medium was removed, washed twice with DPBS and serum-free medium RPMI 
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1640 added. After 24h serum-starvation, plate for treatment groups were treated at 43℃ 
for 40 min, and recovery at 37℃ for 1.5, 3, and 5.5h.  Then 0.2ml/well TriReagent was 
added to extract RNA for qRT-PCR analysis. 
 
Sodium arsenite: 
 
Dose-response 
 
H441 cells were seeded in 3×12-well plates (0.4×106 cells/well). After 24h incubation, 
the medium was removed, washed twice with DPBS, and 1 ml/well serum-free medium 
RPMI 1640 added. After 24h serum-starvation, the medium was removed, and 0.8 
ml/well serum-free medium was added. After 30 min pre-incubation, 0.2 ml/well 
sodium arsenic solution at 0, 0.1, 0.5, 1, 5, 10, 20, 50, and 500 µΜ was added. After 
24h treatment, the medium was removed, washed once with PBS and added 0.2 ml/well 
TriReagent to extract RNA for analysis. 
Temporal Analysis 
 
H441 cells were seeded in 3×12 well plates (0.4×106 cells/well). Plate 1: control 1 with 
2h and 4h groups. Plate 2: control 2 with 24h group. Plate 3: control 3 with 48h group. 
After 24h incubation, the medium was removed, washed 2⋅ with DPBS, and 1 ml/well 
serum-free medium RPMI 1640 added. After 24h serum-starvation, the medium was 
removed, and 0.8 ml/well serum-free medium was added.  After 30 min pre-incubation, 
0.2 ml/well sodium arsenic solution at 20 µΜ was added. After 2, 4, 24 and 48h 
treatment, the medium was removed, washed once with PBS and added 0.2 ml/well 
TriReagent to extract RNA for analysis. 
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d. RNA isolation, cDNA synthesis, Real-time PCR 
 
 
Total RNA was harvested and isolated using TriReagent and quantified by measuring absorbance 
(260 nm). 
Use iScript cDNA synthesis reaction kit to make cDNA synthesis reaction mix, 5×iScript 
reaction buffer: reverse transcriptase: H2O: DNase 1 treated RNA = 4: 0.5: 12.5: 3.  Then run the 
iScript cDNA Synthesis program, 25℃ for 5min, 42℃ for 30min, 85℃ for 5min. 
Use Taqman real-time PCR reaction kit to make real-time PCR reaction mix, Taqman 
 
2×mastermix: probe for each gene (ATF4, ZFAND2A, VEGFA, and the housekeeping gene 
RPL32): H2O: cDNA = 10: 1: 7: 2. Place the mix into a 384-well PCR plate, and run by RQ 
Manager in Applied Biosystem PCR machine. 
 
 
e. Statistical analysis 
 
 
Heat shock: 
 
All changes in ZFAND2A and ATF4 cDNA levels were normalized to changes in RPL32. One- 
way ANOVA was conducted to determine whether the mean of each treatment group was 
significantly (p<0.05) different from the untreated group (control group). All statistics were 
performed using EXCEL and SigmaPlot (Systat Software Inc.). Data are represented as mean ± 
SEM or as fold control. 
Sodium arsenite: 
 
All changes in ZFAND2A and VEGFA cDNA levels were normalized to changes in RPL32. 
One-way ANOVA was conducted to determine whether the mean of each treatment group was 
significantly (p<0.05) different from the untreated group (control group).   All statistics were 
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performed using RQ Manager (Applied Biosystems Software Informer 2.2) and SigmaPlot 
(Systat Software Inc.).  Data are represented as mean ± SEM or as fold control. 
 
 
 
5.3 RESULTS 
 
 
a. Heat shock cell stress 
 
ZFAND2A transcript increased in cells treated with 43℃  group (log 2 = 1.76 or 3.4-fold) as 
compared to cells maintained at 37℃ (Control) (Figure 1).   Cells treated with 39℃ or 41℃ 
were not significantly different from cells maintained at 37℃.  ATF4 mRNA levels are not 
statistically different from control. 
 
 
 
 
Figure 1.  Temperature-dependent increase in zinc finger, AN1-type  domain 2A (ZFAND2A) 
transcript in H441 cells treated for 30min with a 1.5h recovery (at 37℃). 
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ZFAND2A transcripts significantly increased after 43oC whereas activating transcription factor 4 
(ATF4) transcripts were not significantly different from 37oC control. Transcript level were 
measured by qRT-PCR and normalized to RPL32.  Values are the mean of 3 trials with standard 
error and statically assessed using ANOVA. 
Heat-induced increased ZFAND2A transcripts in H441 cells peaked at 1.5 h recovery 
after treatment with 43℃  for  40min (Figure 2).  The changes in 1.5h recovery following 40 min 
was log2 = 3.47-fold, which was greater than that produced by 30 min treatment (Figure 1). 
ZFAND2A remain greater than control with the 3 h recovery but was not statistically different 
from control at 5.5 h.  ATF4 transcript levels were not statistically different from control. 
 
 
 
 
 
Figure 2. Recovery for heat shock treatment at 43℃ for 40 min of zinc finger, AN1-type domain 2A 
 
(ZFAND2A) transcripts in H441 cells. 
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ZFAND2A transcripts significantly increased following recovery periods of 1.5 h and 3 h after 
43oC whereas activating transcription factor 4 (ATF4) transcripts were not significantly different 
from 37oC control.  Transcript level were measured by qRT-PCR and normalized to RPL32. 
Values are the mean of 3 trials with standard error and statically assessed using ANOVA. 
 
 
b. Arsenic-induced cell stress 
 
 
ZFAND2A transcripts increased in a concentration dependent manner with sodium arsenite 
treatment in H441 cells (Figure 3). The change relative to control is statistically significant at 
doses of >10 µΜ sodium arsenite.  The response continued to increase with increasing doses and 
500 µΜ sodium arsenite induced the maximal response of log 2 = 5.30 fold. H441 cells appear 
to be relatively resistant to arsenic exposure because this dose can produce cytotoxicity in other 
cells (Dodmane et al. 2013). 
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Figure 3. Concentration dependent increases in ZFAND2A transcripts in H441 cells treated with 
sodium arsenite for 24 h. 
 
Doses > 10 µM were statistically different from control.  Transcript level were measured by 
 
qRT-PCR and normalized to RPL32.  Values are the mean of 3 trials with standard error and 
statically assessed using ANOVA. 
ZFAND2A transcripts increased with increasing time of 20 µM sodium arsenite treatment 
(Figure 4). The increase for each time is statistically significant compared to untreated control. 
The increase at 48 h was greater than that at 24 h, again suggesting that H441 cells are resistant 
to sodium arsenite treatment. 
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Figure 4. Concentration dependent increases in NaAsO2 dose response for 24h treatment ZFAND2A 
expression transcription H441 cell, in H441 cells treated with sodium arsenite for 24 h. 
 
Transcript level were measured by qRT-PCR and normalized to RPL32.  Values are the mean of 
3 trials with standard error and statically assessed using ANOVA. 
 
Vascular endothelial growth factor A (VEGFA), a member of the vascular endothelial 
growth factor (VEGF) family, encodes a protein that is often found as a disulfide linked 
homodimer.  Epithelial cell can be a major source of this protein in the lung (Acarregui 1999; 
Christou 1998).  VEGFA is also important for normal lung development (Acarregui 1999) and 
airway epithelial cell proliferation (Brown 2001).  VEGFA plays a role in angiogenesis and 
vascularization, however, its role in lung injury and diseases remains controversial (Mura 2004). 
In the initial phase of inflammation lung diseases, such as asthma and acute lung injury, the 
expression level of this gene is increased and cause pulmonary edema (Kanazawa 2003; 
McColley 2000; Mura 2004).  While in the later phases, elevated VEGFA is associated with the 
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resolution of acute lung injury (Thickett 2002).  VEGFA transcripts are known to increase with 
arsenite treatment primary vascular smooth muscle cells (Soucy et al. 2004).  After 48 h, sodium 
arsenite also increased VEGFA transcripts in H441 cells (Figure 5). 
 
 
 
 
 
Figure 5. Temporal pattern of increases in vascular endothelial growth factor A (VEGFA) in H441 
cells treatment with 20 µM sodium arsenite. 
 
Transcript level were measured by qRT-PCR and normalized to RPL32.  Values are the mean of 
3 trials with standard error and statically assessed using ANOVA. 
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5.4 DISCUSSION 
 
 
Epidemiological studies have associated arsenic exposure in drinking water with lung 
diseases (Smith 2012, Dauphiné 2011). In this study we investigated whether ZFAND2A is 
regulates by heat- and arsenic-induced cell stress along in human lung cancer cells. We observed 
increases in ZFAND2A following either treatment, suggesting this response may serve to 
detoxify cell stress.   Previously, temperature-dependent increases in ZFAND2A mRNA were 
detected in human cervical carcinoma cell line treated at 41℃, 42℃, and 43℃  for 40 min 
followed by a 1.5 h  recovery  with  43℃ producing the maximum level (Rossi et al., 2010). 
When HeLa-Ps cells were subjected to heat shock at 43℃ for 40 min ZFAND2A mRNA levels 
were greater after a recovery time of 1.5 h than after 3 h (Rossi et al., 2010).  Our results are 
consistent with this temporal pattern (Figure 2).  However, only 43℃ for 30 min (Figure 1) or 40 min (Figure 2) produced a statistically significant increase in ZFAND2A in H441 cells. This 
may be due to a small sample size and a relatively large standard error.  Nonetheless the response 
was notable in that the magnitude of the response was approximately 11-fold increase (log 2 = 
3.47) following 40 min. 
In this study we found that 24 h treatment with >10 µM sodium arsenite increased 
 
ZFAND2A transcripts (Figure 3). This is a relatively high dose of arsenic, in that other have 
observed cytotoxicity in lung epithelial cells at these levels (Dodmane et al. 2013). Although 
lower doses 0.5 µM < X < 5 µM produced essentially a 2 fold increase in ZFAND2A transcripts, 
these value were not statistically significant. This may be due to the shorter duration of exposure 
of 24 h, because a greater response was noted when cells were treated for 48 h (Figure 4). In 
addition, the sample size (n =3) was relative small.  Thus, the evaluation of the threshold dose of 
37  
sodium arsenite that induces ZFAND2A should be conducted with longer exposure and in a 
larger sample size. It would be prudent to attempt exposures greater than 48 h, because it is 
unknown whether ZFAND2A transcripts will continue to increase with exposure of 72 or even 96 
h. Thus,  to  better  understand  this  response  under  arsenic  stress,  exposure  with  lower 
concentration and longer time should be conducted both in and in animal models. 
Former study have reportted that VEGFA could be induced following 1 µΜ or 
 
5 µΜ arsenite treatment for 4h in HMVEC (Human lung microvascular endothelial cells) (Klei 
2008).  In H441cells treated at a much higher concentration 20 µΜ for even longer treatment 
time 24h, the change was not significant. Thus, H441 cells appear to be resistant to sodium 
arsenite.  Cancer cell lines are considered to be much more resistant than primary cell lines under 
varies of cell stresses, thus cancer cells could maintain themselves in a good condition and 
proliferate well even in a poor environment, while primary cells are going to be injured or died. 
Besides, these proteins may act differently in cancer cells than primary cells, VEGFA involves in 
arsenic-induced injury in primary cells, but its function could be varied in cancer cells.  Again, 
these preliminary studies were only conducted with a small sample size, which limits the 
statistical power of our study.  Nonetheless, it seems worthwhile to conduct additional studies 
comparing the responsiveness of ZFAND2A and VEGFA in primary epithelial cells and in 
animal models in future studies.  Lastly,  Given that ZFAND2A may play an important role in 
cell growth and repair mechanism, if the pathways of its protective reaction in cancer cells can 
be demonstrated clearly, then selective inhibition of these proteins may be useful in cancer 
therapy. 
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